Cart
sales@molnova.com
Longdaysin
CAS No. 1353867-91-0
Longdaysin( —— )
Catalog No. M20113 CAS No. 1353867-91-0
Longdaysin is an inhibitor of CK1α and CK1δ (IC50s: 5.6/8.8 μM). It also can inhibit ERK2 (IC50: 52 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 45 | In Stock |
|
| 5MG | 41 | In Stock |
|
| 10MG | 67 | In Stock |
|
| 25MG | 135 | In Stock |
|
| 50MG | 211 | In Stock |
|
| 100MG | 319 | In Stock |
|
| 200MG | 458 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLongdaysin
-
NoteResearch use only, not for human use.
-
Brief DescriptionLongdaysin is an inhibitor of CK1α and CK1δ (IC50s: 5.6/8.8 μM). It also can inhibit ERK2 (IC50: 52 μM).
-
DescriptionLongdaysin is an inhibitor of CK1α and CK1δ (IC50s: 5.6/8.8 μM). It also can inhibit ERK2 (IC50: 52 μM).
-
In VitroWestern Blot Analysis Cell Line:HEK293T cells Concentration:0-50 μM Incubation Time:24 h Result:Reduced the levels of phosphorylated LRP6, total LRP6, phosphorylated DVL2, activated β-catenin, and total β-catenin.
-
In VivoAnimal Model:MDA-MB-231 xenografts Dosage:5 mg/kg Administration:i.p., every 3 days for 3 weeks Result:Decreased tumor cell density and proliferation (indicated by Ki-67).Reduced the expression of active and total β-catenin, and decreased the expression of phosphorylated and total LRP6, phosphorylated DVL2, and active and total β-catenin.Reduced mRNA expression of the Wnt target genes including Axin2, DKK1, LEF1, and Survivin.
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetCasein Kinase
-
RecptorCKIα| CKIδ|CDK7|ERK2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1353867-91-0
-
Formula Weight335.33
-
Molecular FormulaC16H16F3N5
-
Purity>98% (HPLC)
-
SolubilityDMSO: 100 mg/mL (298.21 mM);Water: Insoluble
-
SMILESCC(C)n1cnc2c(NCc3cccc(c3)C(F)(F)F)ncnc12
-
Chemical Name9-Isopropyl-N-(3-(trifluoromethyl)benzyl)-9H-purin-6-amine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hirota T et al. High-throughput chemical screen identifies a novel potent modulator of cellular circadian rhythms and reveals CKIα as a clock regulatory kinase. PLoS Biol. 2010 Dec 14;8(12):e1000559.
molnova catalog
related products
-
Epiblastin A
Epiblastin A is an inhibitor of Casein Kinase 1 (CK1).?Epiblastin A engages CK1 isoenzymes in cell lysate and induces efficient conversion of epiblast stem cells (EpiSCs) into embryonic stem cells (cESCs).
-
CK2-IN-1
CK2-IN-1 is a potent, competitive inhibitor of ATP binding to Casein kinase 2(CK2) with IC50 of 9 nM.
-
BTX161
BTX161 is a thalidomide analog that mediates degradation of CKIα better than lenalidomide in human AML cells and activates DDR and p53.
